The NHS paid an extra £625 million on synthetic insulin over the past decade
Research published online in BMJ Open reveals that the NHS paid an extra £625 million on synthetic forms of insulin over the past decade, when the considerably cheaper recommended human alternatives would have probably been just as effective.
The annual cost for diabetes treatment nearly doubled in only six years from $6.7 billion in 2001 to $12.5 billion in 2007, according to a study published in the Oct 27 2008 issue of the Archives of Internal Medicine.